Table 4
Guidelines for platelet transfusion in the newborn
| Platelet count (× 109/l) | Non-bleeding neonate | Bleeding neonate | NAITP (proven or suspected) |
|---|---|---|---|
| NAITP, Neonatal alloimmune thrombocytopenia; HPA, human platelet antigen; IVH, intraventricular haemorrhage; ET, endotracheal. | |||
| <30 | Consider transfusion in all patients | Transfuse | Transfuse (with HPA compatible platelets) |
| 30–49 | Do not transfuse if clinically stable | Transfuse | Transfuse (with HPA compatible platelets if any bleeding) |
Consider transfusion if:
|
|||
| 50–99 | Do not transfuse | Transfuse | Transfuse (with HPA compatible platelets if major bleeding present) |
| >99 | Do not transfuse | Do not transfuse | Do not transfuse |
